Video
Dr. Matulewicz explains the need for urologists to promote smoking cessation
Author(s):
“Cigarette smoking and continued smoking exposes patients [with bladder cancer] to a lot of continued risk, and I don't think we're doing our job as a doctor by ignoring this critical part of counseling and education,” says Dr. Matulewicz.
Video Player is loading.
In this interview, Richard S. Matulewicz, MD, MSCI, MS, emphasizes the need for urologists to take a more active role in patient education based on findings from his recent study, “Knowledge of bladder cancer risk factors among patients diagnosed with non–muscle-invasive bladder cancer”. Matulewicz is a urologic oncologist and surgeon at Memorial Sloan Kettering Cancer Center in New York, New York.
Related Videos
Study data point to gender disparities in oncology research citations
Matthew Galsky, MD, on patient selection for perioperative durvalumab/chemo in MIBC
Suzanne B. Merrill, MD, FACS, discusses rBCG and the NMIBC landscape
Expert describes implications of neoadjuvant durvalumab approval in MIBC
Sima Porten, MD, on gene-environment interactions in bladder cancer development
How rBCG EAP could open up access for Anktiva in bladder cancer
Betty Wang, MD, recaps 3 key urologic cancer studies from EAU 2025
Joshua J. Meeks, MD, PhD, discusses the impact of neoadjuvant durvalumab approval in MIBC
Matthew Galsky, MD, reacts to NIAGARA results, durvalumab approval for MIBC
Sima Porten, MD, discusses the need to educate on the firefighter-bladder cancer link
Related Content
